-
EP2229172
European procedure
Extract from the Register of European Patents
EP About this file: EP2229172
| EP2229172 - TICAGRELOR FOR TREATMENT OF ABDOMINAL AORTIC ANEURYSMS [Right-click to bookmark this link] | |||
| Former [2010/38] | TRIAZOLO [4,5-D] PYRIMIDINE COMPOUNDS FOR TREATMENT OF ABDOMINAL AORTIC ANEURYSMS | ||
| [2014/16] | Status | No opposition filed within time limit Status updated on 17.07.2015 Database last updated on 26.04.2025 | Most recent event Tooltip | 03.06.2016 | Lapse of the patent in a contracting state ???moredetails.lapse.edited??? MC | published on 06.07.2016 [2016/27] | Applicant(s) | For all designated states AstraZeneca AB 151 85 Södertälje / SE | [2010/38] | Inventor(s) | 01 /
MICHEL, Jean-Baptiste INSERM Unit 698 CHU Bichat Claude Bernard 46 Rue Henri Huchard F-75018 Paris / FR | [2014/37] |
| Former [2010/38] | 01 /
MICHEL, Jean-Baptiste INSERM Unit 698 CHU Bichat Claude Bernard 46 Rue Henri Huchard F-75018 Paris / FR | Representative(s) | Berry, Ian Gordon, et al AstraZeneca Intellectual Property Milstein Building Granta Park Cambridge CB21 6GH / GB | [N/P] |
| Former [2014/37] | Berry, Ian Gordon, et al AstraZeneca Global Intellectual Property Patents Mereside - Alderley Park Macclesfield, Cheshire SK10 4TG / GB | ||
| Former [2010/38] | Berry, Ian Gordon, et al AstraZeneca Global Intellectual Property Patents Mereside - Alderley Park GB-Macclesfield, Cheshire SK10 4TG / GB | Application number, filing date | 08857354.8 | 02.12.2008 | [2010/38] | WO2008SE51386 | Priority number, date | EP20070301616 | 03.12.2007 Original published format: EP 07301616 | [2010/38] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2009072967 | Date: | 11.06.2009 | Language: | EN | [2009/24] | Type: | A1 Application with search report | No.: | EP2229172 | Date: | 22.09.2010 | Language: | EN | The application published by WIPO in one of the EPO official languages on 11.06.2009 takes the place of the publication of the European patent application. | [2010/38] | Type: | B1 Patent specification | No.: | EP2229172 | Date: | 10.09.2014 | Language: | EN | [2014/37] | Search report(s) | International search report - published on: | SE | 11.06.2009 | (Supplementary) European search report - dispatched on: | EP | 26.11.2012 | Classification | IPC: | A61K31/519, A61P9/00, A61P9/10 | [2010/38] | CPC: |
A61K31/519 (EP,US);
A61P35/00 (EP);
A61P43/00 (EP);
A61P9/00 (EP);
A61P9/10 (EP);
A61P9/14 (EP)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2010/38] | Extension states | AL | 05.07.2010 | BA | 05.07.2010 | MK | 05.07.2010 | RS | 05.07.2010 | Title | German: | TICAGRELOR ZUR BEHANDLUNG VON BAUCHAORTENANEURYSMEN | [2014/18] | English: | TICAGRELOR FOR TREATMENT OF ABDOMINAL AORTIC ANEURYSMS | [2014/18] | French: | TICAGRELOR POUR LE TRAITEMENT D'ANÉVRYSMES AORTIQUES ABDOMINAUX | [2014/18] |
| Former [2010/38] | TRIAZOLO [4,5-D]PYRIMIDIN-VERBINDUNGEN ZUR BEHANDLUNG VON BAUCHAORTENANEURYSMEN | ||
| Former [2010/38] | TRIAZOLO [4,5-D] PYRIMIDINE COMPOUNDS FOR TREATMENT OF ABDOMINAL AORTIC ANEURYSMS | ||
| Former [2010/38] | COMPOSÉS DE TRIAZOLO [4,5-D] PYRIMIDINE POUR LE TRAITEMENT D'ANÉVRYSMES AORTIQUES ABDOMINAUX | Entry into regional phase | 05.07.2010 | National basic fee paid | 05.07.2010 | Search fee paid | 05.07.2010 | Designation fee(s) paid | 05.07.2010 | Examination fee paid | Examination procedure | 05.07.2010 | Examination requested [2010/38] | 07.06.2013 | Amendment by applicant (claims and/or description) | 03.07.2013 | Despatch of a communication from the examining division (Time limit: M06) | 07.01.2014 | Reply to a communication from the examining division | 31.03.2014 | Communication of intention to grant the patent | 29.07.2014 | Fee for grant paid | 29.07.2014 | Fee for publishing/printing paid | 29.07.2014 | Receipt of the translation of the claim(s) | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 03.07.2013 | Opposition(s) | 11.06.2015 | No opposition filed within time limit [2015/34] | Fees paid | Renewal fee | 03.01.2011 | Renewal fee patent year 03 | 02.01.2012 | Renewal fee patent year 04 | 02.01.2013 | Renewal fee patent year 05 | 02.01.2014 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | MC | 10.09.2014 | [2016/27] |
| Former [2015/18] | deleted | ||
| Former [2015/12] | LV | 10.09.2014 | Documents cited: | Search | [E]WO2009007675 (CARDOZ AB [SE], et al) [E] 1-8* page 44, lines 32-33 - page 45; example 19 *; | [XY] - R.T. OWEN ET AL, "AZD6140", DRUGS OF THE FUTURE, (20070101), vol. 32, no. 10, doi:10.1358/dof.2007.032.10.1133832, ISSN 0377-8282, page 845, XP055024216 [X] 1-8 * abstract * [Y] 1-8 DOI: http://dx.doi.org/10.1358/dof.2007.032.10.1133832 | [Y] - ETANI H ET AL, "[Platelet accumulation in abdominal aortic aneurysms and the effect of antiplatelet drugs: assessment by indium platelet scintigraphy].", MEDLINE, US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US, (199206), Database accession no. NLM1640649, XP002687010 [Y] 1-8 * abstract * | [ ] - KAKU IGAKU. THE JAPANESE JOURNAL OF NUCLEAR MEDICINE JUN 1992, (199206), vol. 29, no. 6, ISSN 0022-7854, pages 651 - 657 | [Y] - LLOYD G M ET AL, "Patients with abdominal aortic aneurysm: Are we missing the opportunity for cardiovascular risk reduction?", JOURNAL OF VASCULAR SURGERY, C.V. MOSBY CO., ST. LOUIS, MO, US, (20041001), vol. 40, no. 4, doi:10.1016/J.JVS.2004.06.039, ISSN 0741-5214, pages 691 - 697, XP004584815 [Y] 1-8 * page 691, paragraphs 1-2 * DOI: http://dx.doi.org/10.1016/j.jvs.2004.06.039 | [A] - DIEHM N ET AL, "Current evidence and prospects for medical treatment of abdominal aortic aneurysms", VASA, (200511), vol. 34, no. 4, ISSN 0301-1526, pages 217 - 223, XP009164626 [A] 1-8 * part with heading "Drug Treatment"; page 219 - page 221 * DOI: http://dx.doi.org/10.1024/0301-1526.34.4.217 | International search | [A]WO9703084 (ASTRA PHARMA PROD [GB], et al); | [A]WO9905143 (ASTRA PHARMA PROD [GB], et al); | [X]WO0034283 (ASTRAZENECA UK LTD [GB], et al); | [X]WO0192262 (ASTRAZENECA AB [SE], et al); | [X]WO02096428 (ASTRAZENECA AB [SE], et al); | [X]EP1493745 (ASTRAZENECA AB [SE]); | [X]US2007265282 (HARDERN DAVID [GB], et al) |